US Patent Issued to LG CHEM on March 25 for "Injectable composition containing prodrug of caspase inhibitors, and preparation method therefor" (South Korean Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,341, issued on March 25, was assigned to LG CHEM Ltd. (Seoul, South Korea).

"Injectable composition containing prodrug of caspase inhibitors, and preparation method therefor" was invented by Sung Won Kim (Seoul, South Korea), Jae Uk Baek (Seoul, South Korea), Hyun Seo Park (Seoul, South Korea), Myung Won Jin (Seoul, South Korea), Jung Gyu Park (Seoul, South Korea), Bok Tae Kim (Seoul, South Korea) and Sei Hyun Choi (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an injectable pharmaceutical composition containing a prodrug of caspase inhibitors, and a preparation method therefor. More specifically...